Novartis and its partners invested heavily in expanding production capacity at their facilities in China, and Suffern, New York. This increase in production capacity ensured that supplies of Coartem met demand which enabled Novartis to further decrease the price of Coartem.
Novartis and its partners invested heavily in increasing production capacity at their China and Suffern, New York sites. This increase allowed for adequate Coartem supplies to satisfy demand, facilitating further reductions in the Coartem cost.